Xiaobo Wang
Impact in
- Cell Biology top 0.5%
- Caveolin-1 and cellular processes
- Geriatrics and Gerontology top 1%
Papers in
-
- Genomics, phytochemicals, and oxidative stress 7
- Metabolism, Diabetes, and Cancer 6
- Epidemiology 30
- Autophagy in Disease and Therapy 14
- Co-authors
- Michael P. Lisanti (11 shared papers)Frederick F. Becker (7 shared papers)Peter R. C. Gascoyne (7 shared papers)Babak Razani (6 shared papers)Ying Huang (6 shared papers)Yuchen Ge (11 shared papers)Chen Cui (2 shared papers)Jun Yang (4 shared papers)
- Journals
- International Immunopharmacology (9 papers)Biochemical and Biophysical Research Communications (6 papers)Frontiers in Pharmacology (5 papers)Scientific Reports (4 papers)Journal of Biological Chemistry (4 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Xiaobo Wang
157 papers receiving 7.5k citations
Xiaobo Wang's Hit Papers
Peers
Comparison fields: 5 of 171
- Cell Biology 2.1k
- Geriatrics and Gerontology 284
- Aging 121
- Physiology 1.3k
- Molecular Biology 3.3k
Countries citing papers authored by Xiaobo Wang
This map shows the geographic impact of Xiaobo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Wang more than expected).
Fields of papers citing papers by Xiaobo Wang
This network shows the impact of papers produced by Xiaobo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Wang. The network helps show where Xiaobo Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 170 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities Hit paper breakdown → | 2001 | 975 |
| 2 | SIRT1 and aging related signaling pathways Hit paper breakdown → | 2020 | 480 |
| 3 | 2002 | 467 | |
| 4 | 2000 | 322 | |
| 5 | 2003 | 298 | |
| 6 | 2002 | 263 | |
| 7 | 2004 | 258 | |
| 8 | 1999 | 255 | |
| 9 | 2016 | 252 | |
| 10 | 2016 | 245 | |
| 11 | 2000 | 173 | |
| 12 | Role of AMPK mediated pathways in autophagy and aging Hit paper breakdown → | 2021 | 172 |
| 13 | 2014 | 153 | |
| 14 | 2002 | 137 | |
| 15 | 1998 | 131 | |
| 16 | 2017 | 130 | |
| 17 | 2008 | 130 | |
| 18 | 2001 | 128 | |
| 19 | 2014 | 126 | |
| 20 | 2003 | 119 |
About Xiaobo Wang
Xiaobo Wang is a scholar working on Molecular Biology, Epidemiology, Oncology, Cell Biology and Immunology, having authored 170 papers that have together received 7.7k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (14 papers), Caveolin-1 and cellular processes (10 papers), Sirtuins and Resveratrol in Medicine (9 papers), Telomeres, Telomerase, and Senescence (8 papers), Genomics, phytochemicals, and oxidative stress (7 papers), Microfluidic and Bio-sensing Technologies (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Psoriasis: Treatment and Pathogenesis (6 papers). The work is most often cited by research in Cell Biology (2.1k citations), Geriatrics and Gerontology (284 citations), Aging (121 citations), Physiology (1.3k citations) and Molecular Biology (3.3k citations). Xiaobo Wang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Michael P. Lisanti, Frederick F. Becker, Peter R. C. Gascoyne, Babak Razani, Ying Huang, Yuchen Ge, Chen Cui, Jun Yang, Philipp E. Scherer and Min Zhou. Their work appears in journals such as International Immunopharmacology, Biochemical and Biophysical Research Communications, Frontiers in Pharmacology, Scientific Reports and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.